To assess the impact of genotypic susceptibility score (GSS) on combined antiretroviral therapy (cART) outcomes during primary HIV infection (PHI) we retrospectively enrolled patients with PHI diagnosed between 2008 and 2015 at 9/24 Italian Network ACuTe HIV InfectiON centers. One hundred-seventy-six patients were enrolled. Of these, 55 (32.9%) patients started with more than three drugs and 11 (7.2%) started with a GSS < 3. Regimen's GSS (per 1 point increase) (adjusted odds ratio [aOR], 4.82; 95% confidence interval [CI], 1.62-14.28; P =.005) and baseline HIV-RNA (per 1 log10 increase) (aOR, 2.02; 95% CI, 1.09-3.73; P =.025) resulted associated with early cART initiation. In conclusion, regimen's GSS resulted to be associated to the time to cART initiation during PHI.

Impact of genotypic susceptibility score on cART outcomes during primary HIV infection / Giacomelli, A.; Fabbiani, M.; De Benedetto, I.; Nozza, S.; Foca, E.; Celesia, B. M.; Marchetti, G.; Mussini, C.; Antinori, A.; D'Ettorre, G.; Madeddu, G.; Bandera, A.; Muscatello, A.; Rusconi, S.. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - 91:10(2019), pp. 1891-1895. [10.1002/jmv.25517]

Impact of genotypic susceptibility score on cART outcomes during primary HIV infection

Madeddu, G.;
2019-01-01

Abstract

To assess the impact of genotypic susceptibility score (GSS) on combined antiretroviral therapy (cART) outcomes during primary HIV infection (PHI) we retrospectively enrolled patients with PHI diagnosed between 2008 and 2015 at 9/24 Italian Network ACuTe HIV InfectiON centers. One hundred-seventy-six patients were enrolled. Of these, 55 (32.9%) patients started with more than three drugs and 11 (7.2%) started with a GSS < 3. Regimen's GSS (per 1 point increase) (adjusted odds ratio [aOR], 4.82; 95% confidence interval [CI], 1.62-14.28; P =.005) and baseline HIV-RNA (per 1 log10 increase) (aOR, 2.02; 95% CI, 1.09-3.73; P =.025) resulted associated with early cART initiation. In conclusion, regimen's GSS resulted to be associated to the time to cART initiation during PHI.
2019
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection / Giacomelli, A.; Fabbiani, M.; De Benedetto, I.; Nozza, S.; Foca, E.; Celesia, B. M.; Marchetti, G.; Mussini, C.; Antinori, A.; D'Ettorre, G.; Madeddu, G.; Bandera, A.; Muscatello, A.; Rusconi, S.. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - 91:10(2019), pp. 1891-1895. [10.1002/jmv.25517]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/225284
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact